ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-22.09	-16.44	-14.41	-6.78	-5.54
Depreciation & Amortization	1.46	0.78	0.69	0.55	0.25
Share-Based Compensation	6.08	4.13	2.08	1.09	0.8
Other Operating Activities	0.83	-4.64	-1.06	-2.67	1.64
Operating Cash Flow	-13.72	-16.17	-12.7	-7.81	-2.85
Capital Expenditures	-1.05	-1.15	-0.17	-0.48	-0.16
Change in Investments	10	-9.59	0	0	0
Investing Cash Flow	8.95	-10.74	-0.17	-0.48	-0.16
Share Issuance / Repurchase	0.51	0.75	47.47	0.38	7.82
Debt Issued / Paid	0	0	0	22.32	-2.21
Other Financing Activities	-0.21	-0.34	-0.6	-	-
Financing Cash Flow	0.3	0.41	46.88	22.69	5.61
Net Cash Flow	-4.48	-26.49	34.01	14.4	2.6
Free Cash Flow	-14.77	-17.31	-12.87	-8.29	-3.01
Free Cash Flow Margin	-61.66%	-84.24%	-78.93%	-64.61%	-26.83%
Free Cash Flow Per Share	-0.60	-0.72	-0.62	-0.52	-0.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).